title: [New drugs for tuberculosis: are they necessary in Brazil?].
authors.forename: F A
authors.initials: FA
authors.lastname: de Melo
authors.forename: F
authors.initials: F
authors.lastname: Cestari Filho
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use; D001938:Brazil; D002908:Chronic Disease; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009268:Nalidixic Acid / Q000031:analogs & derivatives*; D012293:Rifampin / Q000031:analogs & derivatives*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D009268:Nalidixic Acid; D012293:Rifampin
vernacular_title: Novas drogas para tuberculose: são necessárias no Brasil?